Vancouver street youth face an alarmingly high risk of hepatitis C infection because of a high incidence of injection drug use, according to a new study published in the British Medical Journal.
The B.C. Centre for Excellence in HIV/AIDS tracked youth aged 14 to 26 over the course of six years.
Of 940 people recruited between September 2005 and November 2011, 100 tested positive for the disease at the outset.
Of the people 512 who tested negative at the beginning and showed up for at least one subsequent visit, 56 were positive in follow-up tests – 10.9 per cent.
And of those 512 youth, 166 – about 32 per cent – reported prior use of injection drugs.
“We found that the risk for (hepatitis C virus) acquisition among street youth in this setting was alarmingly high, and that intravenous drug injection remains a primary risk factor,” said the study, led by Dr. Scott Hadland.
The study was also the first to look at the risk of hepatitis infection from injecting opioids like oxycodone and morphine, which is on the rise throughout North America.
CBC News
Read The Full Story